Immunological Considerations for Schistosoma Vaccine Development: Transitioning to Endemic Settings. (2021)
Attributed to:
Immunomodulation and Vaccines
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2021.635985
PubMed Identifier: 33746974
Publication URI: http://europepmc.org/abstract/MED/33746974
Type: Journal Article/Review
Volume: 12
Parent Publication: Frontiers in immunology
ISSN: 1664-3224